Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Chem Biol Drug Des. 2014 Nov 6;85(6):702–714. doi: 10.1111/cbdd.12453

Figure 4.

Figure 4

A) Effect of compounds on HER2 expression studied by flow cytometry. BT-474 cells without any FITC-labeled antibody to HER2, BT474 cells with FITC-antiHER2, cells treated with lapatinib and labeled with FITC-anti-HER2, cells treated with compound 9 with FITC-anti-HER2. B) Cell treated with compound 5.